Seasilver

From WikiMD's WELLNESSPEDIA

Seasilver is a liquid dietary supplement that was marketed as a cure-all product. It was promoted as a product that could provide nutritional support to the body's five main systems: the digestive system, the immune system, the respiratory system, the circulatory system, and the endocrine system. However, the product has been the subject of controversy and legal action due to unsupported health claims.

History[edit]

Seasilver was created by Brett Rademacher and Jason Rhode. The product was marketed by Seasilver USA, Inc., a company based in Carlsbad, California. The company claimed that Seasilver could treat or cure a variety of health conditions, including cancer, diabetes, and arthritis. However, these claims were not supported by scientific evidence.

In 2003, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) took action against Seasilver USA, Inc. for making false and misleading health claims about Seasilver. The company was ordered to stop making these claims and to provide refunds to consumers who had purchased the product.

Composition[edit]

Seasilver contained a blend of amino acids, vitamins, minerals, and herbs. The product also contained aloe vera, pau d'arco, and cranberry concentrate. However, the exact composition of Seasilver was not disclosed by the company.

Controversy and legal action[edit]

The FDA and FTC took action against Seasilver USA, Inc. in 2003. The agencies claimed that the company had made false and misleading health claims about Seasilver. The company was ordered to stop making these claims and to provide refunds to consumers who had purchased the product.

In 2004, the company agreed to a settlement with the FTC. As part of the settlement, the company agreed to pay $120 million in consumer redress. The company also agreed to stop making unsupported health claims about Seasilver.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.